ONYX PHARMACEUTICALS INC's ticker is ONXX and the CUSIP is 683399109.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2013 | $246,487,000 | – | 1,976,636 | – | 9.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 1,325,115 | $115,046,000 | 13.58% |
Meditor Group Ltd | 962,103 | $83,530,000 | 11.31% |
Redmile Group, LLC | 393,981 | $34,205,000 | 6.03% |
SECTORAL ASSET MANAGEMENT INC | 1,356,043 | $117,732,000 | 3.48% |
BB BIOTECH AG | 546,500 | $47,447,000 | 3.42% |
SECTOR GAMMA AS | 129,815 | $11,271,000 | 3.29% |
Tekla Capital Management LLC | 253,856 | $22,040,000 | 3.00% |
BENNETT LAWRENCE MANAGEMENT L L C/NY | 178,580 | $15,505,000 | 2.96% |
APEX CAPITAL, LLC | 440,800 | $38,270,000 | 2.61% |
GRAYBILL WEALTH MANAGEMENT, LTD. | 32,368 | $2,810,000 | 2.52% |